知情人士称，医疗设备生产商Becton Dickinson & Co．正在考虑可能剥离其生命科学业务部门，该部门估值可能约为300亿美元。 知情人士称，在寻求提振 ...

【Becton Dickinson考虑剥离生命科学业务】财联社2月3日电，知情人士称，医疗设备生产商Becton Dickinson & Co.正在考虑可能剥离其生命科学业务 ...

Becton Dickinson plans to break off its biosciences and diagnostic solutions business and focus on the medtech sector. The company said late Wednesday the split could take the form of a sale ...

Becton Dickinson Announces Strategic Business Separation Plan BD sees FY25 adjusted EPS $14.30-$14.60 vs. previous view $14.25-$14.60 Becton Dickinson to separate biosciences, diagnostic solutions ...

Activist investor Starboard Value has taken a position in Becton Dickinson, sending the shares up modestly on Feb. 3. Why it matters: BD shares have been some of the worst performing in the ...

(This Feb. 5 story has been refiled to correct the name of the unit to biosciences and diagnostic solutions, from life sciences, in the headline and paragraphs 1 and 4) (Reuters) - Becton Dickinson ...

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Becton Dickinson (NYSE:BDX). Even if this company is fairly valued by ...

BofA analyst Travis Steed raised the firm’s price target on Becton Dickinson (BDX) to $269 from $265 and keeps a Buy rating on the shares after the company reported fiscal Q1 EPS and announced ...